News

MHRA grants approval for second Pfizer/Biontech bivalent Covid-19 booster vaccine

0
Biochemistry laboratory research, Scientist or medical in lab coat holding test tube with Using Microscope reagent with drop of color liquid over glass equipment working at the laboratory.

Approval has today been granted by the Medicines and Healthcare products Regulatory Agency (MHRA) for a Pfizer/BioNTech ‘bivalent’ Covid vaccine that targets both the Original strain of SARS-CoV-2 and the Omicron BA.4 and BA.5 sub-variants.

COVID-19 ‘test to treat’ sites less accessible to many marginalized communities

Previous article

Virtual Reality for Promoting Well-Being

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in News